GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment
- 1 August 2017
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 64, 296-307
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund
- Programa Operacional Temático Factores de Competitividade (007491)
- Fundação para a Ciência e a Tecnologia (PTDC/NEU-BEN/0156/2012, UID/Multi /00709/2013)
- Universitat de Barcelona
This publication has 56 references indexed in Scilit:
- GPER: A new tool to protect dopaminergic neurons?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015
- Parkinson’s disease: animal models and dopaminergic cell vulnerabilityFrontiers in Neuroanatomy, 2014
- Implication of GPER1 in neuroprotection in a mouse model of Parkinson's diseaseNeurobiology of Aging, 2013
- Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson’s diseaseFrontiers in Neuroendocrinology, 2012
- The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's diseaseLife Sciences, 2011
- Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neuronsJournal of Neurochemistry, 2011
- Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosisJournal of Neuroimmunology, 2009
- Microglia-mediated neurotoxicity: uncovering the molecular mechanismsNature Reviews Neuroscience, 2007
- Virtual and biomolecular screening converge on a selective agonist for GPR30Nature Chemical Biology, 2006
- Long‐Term Induction of Tyrosine Hydroxylase Expression: Compensatory Response to Partial Degeneration of the Dopaminergic Nigrostriatal System in the Rat BrainJournal of Neurochemistry, 1995